Virtual Medicinal Product (VMP)
-
Lorazepam 2.5mg tablets
Name Details
Current Name
Lorazepam 2.5mg tablets
|
Start Date
15-10-2002
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- Schedule 4 (CD Benz)
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
N05BA06
BNF |
Current BNF
04010200
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
04010200
|
Start Date
01-02-2005
|
End Date
03-04-2022
|
Previous BNF
15010401
|
Start Date
01-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
42131611000001103 |
04-08-2023 |
|
321295009 |
15-10-2002 |
03-08-2023 |
VMP Ingredients
VMP ingredients table
Lorazepam |
Based on Ingredient Substance |
|
2.5 mg |
|
Name
Lorazepam
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
2.5
Strength and UOM (Dmr)
Parent Products
-
VTM
Lorazepam
-
VMP
(Current) Lorazepam 2.5mg tablets
Virtual Medicinal Product Pack (VMPP) Information